Robert Califf Cytokinetics Inc (CYTK) insider trading activity

Robert Califf is Director of CYTOKINETICS INC. Currently has a direct ownership of 6,003 shares of CYTK, which is worth approximately $333,226. The most recent transaction as insider was on Jan 03, 2022, when has been sold 122 shares (Common Stock) at a price of $46.0 per share, resulting in proceeds of $5,612. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K

0% 3M change

0% 12M change

Total Value Held $333,226

Robert Califf Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2022	BUY Grant, award, or other acquisition	$5,612 $46.0 p/Share	122 Added 1.99%	6,003 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	$5,621 $36.74 p/Share	153 Added 2.54%	5,881 Common Stock
Jul 07 2021	BUY Grant, award, or other acquisition	$613 $19.77 p/Share	31 Added 0.54%	5,728 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	$4,993 $20.98 p/Share	238 Added 4.01%	5,697 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 47.81%	5,459 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	$4,986 $24.44 p/Share	204 Added 30.77%	459 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	$4,988 $19.56 p/Share	255 Added 50.0%	255 Common Stock

Robert Califf

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account